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Acacia polyphenol (AP) extracted from the bark of the black wattle tree (Acacia mearnsii) is rich in unique catechin-like ﬂavan-3-
ols,suchasrobinetinidolandﬁsetinidol.Inaninvitrostudy,wemeasuredtheinhibitoryactivityofAPonlipaseandglucosidase.In
addition,weevaluatedtheeﬀectsofAPonabsorptionoforallyadministeredoliveoil,glucose,maltose,sucroseandstarchsolution
inmice.WefoundthatAPconcentration-dependentlyinhibitedtheactivityoflipase,maltaseandsucrasewithanIC50 of0.95,0.22
and0.60mgml−1,respectively.InICRmice,oliveoilwasadministeredorallyimmediatelyafteroraladministrationofAPsolution,
and plasma triglyceride concentration was measured. We found that AP signiﬁcantly inhibited the rise in plasma triglyceride
concentration after olive oil loading. AP also signiﬁcantly inhibited the rise in plasma glucose concentration after maltose and
sucrose loading, and this eﬀect was more potent against maltose. AP also inhibited the rise in plasma glucose concentration after
glucose loading and slightly inhibited it after starch loading. Our results suggest that AP inhibits lipase and glucosidase activities,
which leads to a reduction in the intestinal absorption of lipids and carbohydrates.
1.Introduction
Acacia is an evergreen tree belonging to the genus Acacia
in the legume family that is widely found throughout the
Australian and African continents. The extract of Acacia
catechu duramen is called gambir and has long been used
as an astringent and antibacterial to treat stomatitis and
diarrhea in Japan and China. Studies have also reported
that the powdered seeds of A. catechu and A. melanoxylon
exhibit hypoglycemic actions by increasing insulin secretion
in nondiabetic rats and rabbits [1, 2]. In Europe, acacia
polyphenol (AP) extracted from the bark of the black wattle
tree (A. mearnsii) has been used to eliminate wine sediment.
Australian aborigines also eat the young leaves and beans of
A. mollissima.
We previously conducted a study using KKAy mice, a
model for obesity and type 2 diabetes, to evaluate the anti-
obesity and anti-diabetic eﬀects of AP [3]. We found that
AP signiﬁcantly inhibited body weight gain and improved
diabetes and insulin resistance. The anti-obesity actions of
AP appear to be attributable to increased expression of
energy expenditure-related genes in skeletal muscle and liver
and to decreased fatty acid synthesis and fat intake in the
liver. AP also reduces hyperglycemia and hyperinsulinemia
by increasing adiponectin secretion and suppressing tumor
necrosis factor-alpha secretion by white adipocytes, and
elevating the expression of GLUT4 in skeletal muscle, in
addition to reducing obesity.
AP contains about 80% polyphenols with a molec-
ular weight (MW) of 300–3000kDa [4, 5]. In general,
polyphenol constituents with a low MW can easily be
absorbed, compared to higher MW constituents. Low-MW
AP constituents are thought to be absorbed in the intestine,
thereby altering gene expression in KKAy mice while high-
MW AP constituents, which are not thought to be absorbed
into the body, most likely exhibit inhibitory eﬀects against
obesity and diabetes in the gastrointestinal tract. To date,
various natural products containing polyphenols have been
reported to have anti-obesity and anti-diabetic eﬀects by
inhibiting lipase activity and α-glucosidase activity [6–8].
Therefore, to elucidate the action of AP in the intestine,
we conducted in vitro lipase activity inhibition and α-
glucosidase activity inhibition tests. We also performed in
vivo lipid tolerance and carbohydrate tolerance tests in order
to evaluate the eﬀects of AP on lipid and carbohydrate
absorption.2 Evidence-Based Complementary and Alternative Medicine
2. Methods
2.1. Hot Water Extract of Acacia Bark. AP was donated
by Mimozax Co., Ltd. (Hiroshima, Japan) and prepared
accordingtothemethodsreportedbyCutting[9].Brieﬂy,the
powdered bark of South African A. mearnsii was pulverized
and extracted for 30min in a 10-fold volume of hot water
(100◦C), and then dried using a spray drier. The polyphenol
content of the product, as determined by the Stiasny reaction
[10–12], was 83.3%. The number-average MW (Mn) and
weight-average MW (Mw) of AP were 812 and 1280,
respectively, and robinetinidol and ﬁsetinidol were the major
constituents.
2.2. Materials. Orlistat, pancreatic lipase from porcine pan-
creas, maltose, sucrose, glucose, starch, maleic acid and
rat intestinal acetone powder were purchased from Sigma-
AldrichCorp.(St.Louis,MO,USA).Triolein,lecithin,tauro-
cholic acid, bathocuproine, 3-(2)-tert-butyl-4-hydroxyanisol
and acarbose were purchased from Wako Pure Chemical
Industries (Osaka, Japan). All other reagents were commer-
cially available products of the highest available grade.
2.3. Animals. Male ICR mice (4 weeks old) were purchased
from Sankyo Labo Service Corp., Inc. (Tokyo, Japan). Each
mouse was kept at room temperature (22 ± 1◦C) and 55
± 10% humidity with a 12-h light/dark cycle (artiﬁcial
illumination: 08:00–20:00h) and acclimatized for 1 week
before experiments. The present study was conducted in
accordance with the Guiding Principles for the Care and Use
of Laboratory Animals, as adopted by the Committee on
Animal Research of Hoshi University.
2.4. Assay of Pancreatic Lipase Activity In Vitro. Lipase
activity was determined by measuring the rate of release
of oleic acid from triolein [13]. A suspension of 90μmol
triolein, 12.6μmol lecithin and 9.45μmol taurocholic acid
in 9ml of 0.1M Tris buﬀer (pH 7.0) was sonicated for
10min for substrate dissolution. AP (ﬁnal concentration: 0,
0.02, 0.1, 0.25, 0.5, 1.0 or 2.0mgml−1) and orlistat (ﬁnal
concentration: 0, 0.01, 0.1, 1, 10, 100 or 200μgml −1), which
was used as a positive control, were diluted with 0.1M Tris
buﬀer(pH7.0).Next,50μlofpancreaticlipase(2mgml−1 in
Tris buﬀer), 100μl of substrate solution and 100μlo fs a m p l e
solution were mixed and incubation was carried out at 37◦C
for 30min. The mixture was mixed with 1ml of chloroform-
n-heptane (1:1) containing 2% methanol and extracted by
shaking for 5min. The mixture was centrifuged at 1000g for
5min,andtheupperaqueousphasewasremovedbysuction.
Copper reagent (700μl) was then added to the lower organic
phase. The tube was then shaken for 5min and the mixture
was centrifuged at 1000g for 5min, after which 0.5ml of
the upper organic phase (which contained the copper salts
of the extracted fatty acid) was treated with 0.5ml of 0.1%
bathocuproine in chloroform containing 0.05% 3-(2)-tert-
butyl-4-hydroxyanisol, and its absorbance was measured at
490nm using a U-2800 spectrophotometer (Hitachi High
T e c h n o l o g i e s ,T o k y o ,J a p a n ) .
2.5. Assay of α-Glucosidase Activity In Vitro. α-Glucosidase
activity was calculated by measuring the amount of glucose
hydrolyzed from maltose or sucrose [14, 15]. Enzyme
solutions were prepared using rat intestinal acetone powder
as a source of α-glucosidase. One gram of rat intestinal
acetonepowderwashomogenizedwith9mlof0.1Mmaleate
buﬀer (pH 6.9), followed by centrifugation at 1000g for
10min at 4◦C. The supernatant was diluted with 0.1M
maleate buﬀer by 20 times or two times, and was used as
the enzyme solution for the maltase or sucrase reactions,
respectively. AP (ﬁnal concentration: 0, 0.02, 0.1, 0.25, 0.5,
1.0 or 2.0mgml−1) and acarbose (ﬁnal concentration: 0,
0.01, 0.1, 1, 10 or 100μgml −1), which was used as a positive
control, were diluted with 0.1M maleate buﬀer. Next, 200μl
of sample solution and 200μl of maltose substrate solution
(2% w/v in maleate buﬀer) or sucrose substrate solution
(2% w/v in maleate buﬀer) was mixed, and pre-incubated
at 37◦C for 5min. The enzyme reaction was initiated by
adding 200μl of the enzyme solution. The enzyme reaction
was allowed to proceed at 37◦Cf o r6 0 m i n ,a n dw a st h e n
stoppedbyheatingat100◦Cfor10min.Thereactionmixture
was kept on ice, and the mixture was centrifuged at 1000g
for 10min. Glucose in the supernatant was measured using
a commercial assay kit (Glucose CII-Test Wako, Wako Pure
Chemical Industries).
2.6. Oral Olive Oil Tolerance Test in Mice. For the lipid
absorption test, mice were deprived of food for 18h before
the experiment. An AP solution was orally administered at
0.25, 0.5 or 1.0gkg−1 body weight. Olive oil or distilled
water was subsequently administered orally at 5mlkg−1
body weight. Before and at 1.5, 3, 4.5 and 6h after this
administration, 60-μl blood samples were taken from the
eyeground. All samples were collected with a heparin-coated
capillary tube and centrifuged (1000g for 5min) to separate
the plasma. Plasma samples were frozen at –80◦C until assay.
Plasma triglyceride concentrations were measured with a
Triglyceride E-test Wako (Wako Pure Chemical Industries).
2.7. Oral Carbohydrate Tolerance Test in Mice. For carbo-
hydrate absorption tests, mice were deprived of food for
18h before the experiment. An AP solution was orally
administered at 0.25, 0.5 or 1.0gkg−1 body weight. Glucose
(2gkg−1), maltose (2gkg−1), sucrose (4gkg−1) or starch
(4gkg−1) solution, or distilled water, was subsequently
administered orally. Before and at 0.5, 1, 1.5, 2 and 3h
after administration, 60-μl blood samples were taken from
the eyeground. All samples were collected in heparin-coated
capillaries and centrifuged (1000g for 5min) to separate the
plasma. Plasma samples were frozen at –80◦C until assay.
P l a s m ag l u c o s ec o n c e n t r a t i o n sw e r et h e nm e a s u r e dw i t ha
Glucose CII-Test Wako.
2.8. Statistical Analysis. All IC50 values were calculated from
the corresponding dose inhibition curve. To determine
total triglyceride and glucose absorption after lipid or
carbohydrate administration, the triglyceride area under the
plasma concentration-time curve (AUC) up to 6h after oliveEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Inhibitory eﬀects of AP (ﬁlled circle) or orlistat (open
circle) on pancreatic lipase.The inhibitory activity of AP or orlistat
on pancreatic lipase was measured as described in Methods section.
Data represent means ± SD (n = 4).
oil administration and the glucose AUC up to 3h after
carbohydrate solution administration were determined by
the trapezoidal method. ΔAUC was calculated by subtracting
the AUC values from those in the no-olive oil or no-
carbohydrate solution groups. Numerical data are expressed
as means ± SD. Signiﬁcance of diﬀerences was examined by
analysis of variance, followed by Dunnett’s test. Results with
P < .05 were considered to be signiﬁcant.
3. Results
3.1. Inhibitory Eﬀects of AP on Lipase. Figure 1 shows the
inhibitory eﬀects of AP and orlistat on lipase. Orlistat,
a lipase inhibitor used as the positive control, strongly
inhibited lipase activity with an IC50 of 0.85μgml −1.A Pa l s o
concentration-dependently inhibited lipase activity with an
IC50 of 0.95mgml−1.
3.2. Inhibitory Eﬀects of AP on α-Glucosidase. Figure 2 shows
the inhibitory eﬀects of AP and acarbose on maltase and
sucrase. Acarbose, an α-glucosidase inhibitor used as the
positive control, strongly inhibited maltase and sucrase
activity with an IC50 of 0.071 and 0.49μgml −1,r e s p e c t i v e l y .
AP also concentration-dependently inhibited maltase and
sucrase activity with an IC50 of 0.22 and 0.60mgml−1,
respectively.
3.3. Oral Olive Oil Tolerance Test in Mice. Figure 3(a)
shows the plasma triglyceride concentration proﬁles after
oral administration of AP solution and olive oil to mice.
Figure 3(b) depicts the plasma triglyceride ΔA U Cu pt o
6h post-administration. For olive oil alone administration,
plasma triglyceride concentrations were highest at 90min
post-administration, followed by a gradual decline. AP
inhibited the rise in plasma triglyceride concentrations.
Upon administration of 0.5gkg−1 AP, triglyceride ΔAUC
decreased to about 40% that in the olive oil alone group.
3.4.OralCarbohydrateToleranceTestinMice. Figure 4shows
the plasma glucose concentration proﬁles after oral admin-
istration of AP solution and glucose, maltose, sucrose or
starch solution to mice. Figure 5 depicts the plasma glucose
ΔAUC up to 3h post-administration. For glucose, maltose,
or sucrose solution administered alone, the plasma glucose
concentrations were highest at 30min post-administration
and decreased gradually. With administration of 1gkg−1
AP, the rise in the plasma glucose concentrations after
glucose and sucrose loading was signiﬁcantly inhibited. In
addition, the eﬀect of AP on inhibiting the rise in glucose
concentrations was greater after maltose loading than after
glucose or sucrose loading. Administration of 1gkg−1 AP
resulted in a glucose ΔAUC of about 50% that for maltose
alone. Furthermore, AP slightly inhibited the rise in plasma
glucose concentrations after starch loading.
4. Discussion
Obesity is caused by excess caloric intake [16], and this
can be improved by inhibiting pancreatic lipase activity and
by inhibiting or delaying lipid absorption [17]. Inhibition
of α-glucosidase activity and inhibition of carbohydrate
absorption also play an important role in the prevention and
treatment of diabetes [18]. In this study, we performed in
vitro and in vivo experiments to evaluate the eﬀects of AP
on lipid and carbohydrates absorption.
AP signiﬁcantly inhibited the rise in plasma triglyceride
levels after olive oil administration in mice (Figure 3).
This eﬀect, based on results of the in vitro lipase activity
inhibition test, is probably due to inhibition of lipase activity
(Figure 1). The major constituents of AP are robinetinidol
and ﬁsetinidol, whose structures are similar to catechins
[19–22]. Green tea polyphenols, which contain abundant
catechins, at 0.5mgml−1 have also been reported to inhibit
the activity of lipase to about 60% of control values [13];
this inhibitory eﬀect is similar to that of AP observed in
our study. In mice, oral administration of 1gkg−1 apple
polyphenols, which contain abundant proanthocyanidins,
has been shown to inhibit lipid absorption, but apple
polyphenols at 0.2gkg−1 had no eﬀect on lipid absorption
[23]. In our study, oral administration of 0.25gkg−1 AP
to mice signiﬁcantly inhibited lipid absorption, and at
0.5gkg−1 AP, changes in plasma triglyceride levels were
almost the same as those in normal controls (Figure 3). As
green tea polyphenols [24, 25] and apple polyphenols [23,
26]haveconﬁrmedinhibitoryeﬀectsonlipidabsorptionand
obesity in humans, AP, which also inhibits lipid absorption,
may have inhibitory eﬀects against obesity in humans.
AP inhibited the rise in plasma glucose concentrations
after glucose loading (Figures 4 and 5). In the small intestine,
glucose is absorbed into the blood via a sodium-dependent
glucose transporter (SGLT) and glucose transporter (GLUT)4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Inhibitory eﬀects of AP (ﬁlled circle) or acarbose (open circle) on maltase (a) or sucrase (b). The inhibitory activity of AP or
acarbose on maltase or sucrase was measured as described in ‘Methods’ section. Data represent means ± SD (n = 4).
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Figure 3: Olive oil tolerance test in mice. Blood triglyceride concentration proﬁles at 0 and 6h after oral administration of AP and olive oil
(a) and ΔAUC values of blood triglyceride at 6h following oral administration of AP (0–1.0gkg−1) and immediate oral administration of
5ml/kg olive oil (b). ΔAUC was calculated by subtracting the AUC value from that in the no-olive oil group. open circle: no olive oil group
ﬁlled circle: olive oil alone group, open square: olive oil/AP 0.25gkg−1 group, open triangle: olive oil/AP 0.5gkg−1 group, open diamond:
olive oil/AP 1.0gkg−1 group. Data represent means ± SD (n = 8). Dunnett’s test: ∗P < .05, ∗∗P < .01 and ∗∗∗P < .001 versus no-olive oil
group.
[27]. Polyphenols from acerola fruit have been reported to
inhibittheriseinplasmaglucoseconcentrationsafterglucose
loading in mice; this may be attributable to inhibition of
g l u c o s eu p t a k ev i aS G L Ta n dG L U T[ 8]. These ﬁndings
suggest that AP contains constituents similar to polyphenols
from acerola fruit and that these constituents, via inhibi-
tion of glucose uptake, inhibit the rise in plasma glucose
concentrations after glucose loading. AP also signiﬁcantly
inhibited the rise in plasma glucose concentrations after
maltose and sucrose loading in mice (Figures 4 and 5), and
the inhibitory eﬀects were more potent after maltose than
sucrose loading. This ﬁnding corroborates the observation
that maltase inhibitory activity was almost 3-fold higher
than that of sucrase inhibitory activity (Figure 2). Catechins
and catechin gallates, which are present in green tea, have
been reported to have 2- to 4-fold greater inhibitory activity
against maltase than against sucrase [14], suggesting that AP
contains constituents with similar eﬀects. AP also slightlyEvidence-Based Complementary and Alternative Medicine 5
0123
Time after administration (hr)
0
100
200
300
400
G
l
u
c
o
s
e
c
o
n
c
e
n
t
r
a
t
i
o
n
(
m
g
/
d
L
)
(a)
0123
Time after administration (hr)
0
100
200
300
400
G
l
u
c
o
s
e
c
o
n
c
e
n
t
r
a
t
i
o
n
(
m
g
/
d
L
)
(b)
0123
Time after administration (hr)
G
l
u
c
o
s
e
c
o
n
c
e
n
t
r
a
t
i
o
n
(
m
g
/
d
L
)
0
50
100
150
200
250
300
350
(c)
0123
Time after administration (hr)
G
l
u
c
o
s
e
c
o
n
c
e
n
t
r
a
t
i
o
n
(
m
g
/
d
L
)
0
50
100
150
200
250
(d)
Figure 4: Carbohydrate tolerance test in mice. Blood glucose concentration proﬁles at 0–3h after oral administration of AP (0–1.0gkg−1)
followedimmediatelybyoraladministrationofglucose(2gkg−1,a),maltose(2gkg−1,b),sucrose(4gkg −1,c)orstarch(4gkg −1,d)solution.
Open circle: No carbohydrate group, Filled circle: carbohydrate alone group, open square: carbohydrate/AP 0.25gkg−1 group, open triangle:
carbohydrate/AP 0.5gkg−1 group, open diamond: carbohydrate/AP 1.0gkg−1 group. Data represent means ± SD (n = 8).
inhibited the rise in plasma glucose concentrations after
starch loading; this eﬀect was weaker than that after glucose,
maltose and sucrose loading (Figures 4 and 5). Starch in
meals is hydrolyzed ultimately to glucose by amylase and
then absorbed into the body. Blocking amylase activity has
been eﬀective for the treatment of diabetes [28, 29]. Green
tea polyphenols [30]a n db l a c kt e ap o l yp h e n o l s[ 31]s t r o n g l y
inhibit amylase activity, and polyphenols in chestnut astrin-
gent skin inhibit the rise in plasma glucose concentrations
after starch loading [32]. Although the active constituents
of these polyphenols have not been identiﬁed, AP probably
contains constituents similar to these polyphenols.
In similar studies, doses of 5–20mgkg−1 orlistat and
acarbose have been shown to have very potent inhibitory
eﬀects on lipid absorption and on rises in plasma glucose,
respectively [33–35]. These same inhibitory eﬀects were
found in our in vitro s t u d yw i t hA Pa t0 . 5 – 1 . 0 g k g −1 but
were markedly weaker than those of orlistat and acarbose.
Incidentally, orlistat, which inhibits lipid absorption, is
known to have side eﬀects like steatorrhea for long-term
administration in many patients [17]. In contrast, long-
term administration (7 weeks) of AP produced no stool
abnormalities(datanotshown),mostlikelyduetothemilder
lipase activity inhibition of AP than orlistat. Therefore, even
long-term clinical administration of AP is less likely to cause
side eﬀects.
In recent years, polyphenols have been reported to
possess antioxidant-like actions [36, 37]. Also, many of
the natural extracts with antioxidant-like actions showed
the non-speciﬁc inhibition toward lipase and/or glucosidase6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Carbohydrate tolerance tests in mice. ΔAUC values of blood glucose at 0 and 3h in oral administration of AP (0–1.0gkg−1)
followed immediately by oral administration of glucose (2gkg−1,( a ) ,m a l t o s e( 2gk g −1,( b ) ,s u c r o s e( 4gk g −1,( c )o rs t a r c h( 4gk g −1,( d )
solution. ΔAUC is the diﬀerence of AUC and that in the no-carbohydrate group. Data represent means ± SD (n = 8). Dunnett’s test: ∗P <
.05, ∗∗P < .01 and ∗∗∗P < .001 versus no-carbohydrate group.
activities [8, 13, 23, 38]. AP inhibited not only lipase
activities, but also maltase and sucrase activities. AP has also
been reported to have antioxidant activities [39, 40]. These
ﬁndings indicate that AP inhibits these enzyme activities
non-speciﬁcally.
We previously reported that AP exerts anti-obesity and
anti-diabetic eﬀects by altering the expression of obesity-
and diabetes-related genes in skeletal muscle, liver, and white
adipose tissue [3]. In this study, AP showed inhibitory eﬀects
on lipase and glucosidase activities, as well as on the rise
in plasma triglyceride and glucose concentrations after lipid
and carbohydrate loading (Figure 6). These ﬁndings suggest
that the anti-obesity and anti-diabetic eﬀects of AP are
attributable to not only to the absorbable constituents but
also to the non-absorbable constituents that play roles in the
gastrointestinal tract.Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: Hypothetical mechanisms of anti-obesity/diabetic actions of acacia polyphenol.
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